高级检索
    陈茜, 周建英, 黎扬斯. 抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性[J]. 循证医学, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
    引用本文: 陈茜, 周建英, 黎扬斯. 抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性[J]. 循证医学, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
    shu
    CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
    Citation: CHEN Xi, ZHOU Jian-ying, LI Yang-si. Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
    shu

    抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性

    Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(3)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回